Coppola, Sheryl
15  results:
Search for persons X
?
3

Effect of Upadacitinib on the Pharmacokinetics of Rosuvasta..:

Mohamed, Mohamed‐Eslam F. ; Coppola, Sheryl ; Feng, Tian...
Clinical Pharmacology in Drug Development.  10 (2021)  11 - p. 1335-1344 , 2021
 
?
4

A Phase II Study of Venetoclax in Combination With Pomalido..:

Gasparetto, Cristina ; Bowles, Kristian M. ; Abdallah, Al-Ola...
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  11 - p. 775-784 , 2021
 
?
5

Coproporphyrin I Can Serve as an Endogenous Biomarker for O..:

Kalluri, Hari V. ; Kikuchi, Ryota ; Coppola, Sheryl...
Clinical and Translational Science.  14 (2020)  1 - p. 373-381 , 2020
 
?
7

Phase I Study of Venetoclax Plus Daratumumab and Dexamethas..:

Bahlis, Nizar J ; Baz, Rachid ; Harrison, Simon J...
Bahlis , N J , Baz , R , Harrison , S J , Quach , H , Ho , S J , Vangsted , A J , Plesner , T , Moreau , P , Gibbs , S D , Coppola , S , Yang , X , Al Masud , A , Ross , J A , Bueno , O & Kaufman , J L 2021 , ' Phase I Study of Venetoclax Plus Daratumumab and Dexamethasone, With or Without Bortezomib, in Patients With Relapsed or Refractory Multiple Myeloma With and Without t(11;14) ' , Journal of clinical oncology : official journal of the American Society of Clinical Oncology , vol. 39 , no. 32 , pp. 3602-3612 . https://doi.org/10.1200/JCO.21.00443.  , 2021
 
?
14

Shared genetic basis between genetic generalized epilepsy a..:

Stevelink, Remi ; Luykx, Jurjen J ; Lin, Bochao D...
info:eu-repo/semantics/altIdentifier/doi/10.1111/epi.16922.  , 2021
 
1-15